131 related articles for article (PubMed ID: 7700074)
21. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
[TBL] [Abstract][Full Text] [Related]
22. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
[TBL] [Abstract][Full Text] [Related]
23. [Cilazapril replacing captopril in the therapy of medium-severe essential hypertension].
Kovács P; Juhász A; Gábeli T; Karányi Z; Polgár P; Paragh G; Lörincz I; Arnold C
Orv Hetil; 1995 Oct; 136(42):2273-8. PubMed ID: 7478470
[TBL] [Abstract][Full Text] [Related]
24. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
Pathak L; Hiremath ; Kerkar PG; Manade VG
J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
[TBL] [Abstract][Full Text] [Related]
25. Twenty-four-hour blood pressure control: effect of cilazapril on continuous arterial blood pressure during sleep, and physical and mental load in patients with arterial hypertension and sleep apnea.
Grote L; Heitmann J; Schneider H; Ploch T; Penzel T; Peter JH; von Wichert P
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S78-82. PubMed ID: 7700072
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic experience with cilazapril.
Rosenthal JH
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S65-9. PubMed ID: 7898097
[TBL] [Abstract][Full Text] [Related]
27. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
28. [Effect of cilazapril in patients with essential hypertension: effect on cardiac hypertrophy].
Abrahám G; Pogátsa-Murray G; Forster T; Csanády M; Sonkodi S
Orv Hetil; 1996 Jul; 137(29):1583-6. PubMed ID: 8757070
[TBL] [Abstract][Full Text] [Related]
29. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
30. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
31. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Widimský J; Dzúrik R
Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
[TBL] [Abstract][Full Text] [Related]
32. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
Waeber B; Weidmann P; Wohler D; Le Bloch Y
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
34. Nocturnal hypertension and cardiovascular risk: consequences for diagnosis and treatment.
Grote L; Mayer J; Penzel T; Cassel W; Krzyzanek E; Peter JH; von Wichert P
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S26-38. PubMed ID: 7898092
[TBL] [Abstract][Full Text] [Related]
35. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
Joglekar SJ; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
[TBL] [Abstract][Full Text] [Related]
36. [Ambulatory monitoring of blood pressure with a new ACE inhibitor--cilazapril].
Spritzer N; Oigman W
Arq Bras Cardiol; 1993 Sep; 61(3):195-8. PubMed ID: 8110053
[TBL] [Abstract][Full Text] [Related]
37. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
38. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
[TBL] [Abstract][Full Text] [Related]
39. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
Schiffrin EL; Deng LY; Larochelle P
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S51-6. PubMed ID: 7700067
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function.
Shionoiri H; Gotoh E; Takagi N; Takeda K; Yabana M; Kaneko Y
J Cardiovasc Pharmacol; 1988 Feb; 11(2):242-9. PubMed ID: 2452321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
